摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-phenyl-3-p-methoxyphenylacrylic acid | 6968-77-0

中文名称
——
中文别名
——
英文名称
2-phenyl-3-p-methoxyphenylacrylic acid
英文别名
3-(4-methoxy-phenyl)-2-phenyl-acrylic acid;3-(4-Methoxy-phenyl)-2-phenyl-acrylsaeure;3-(4-methoxyphenyl)-2-phenylacrylic acid;α-Phenyl-4-methoxy-zimtsaeure;α-Phenyl-p-methoxy-zimtsaeure;p-Methoxy-α-phenylzimtsaeure;3-(4-Methoxyphenyl)-2-phenylprop-2-enoic acid
2-phenyl-3-p-methoxyphenylacrylic acid化学式
CAS
6968-77-0
化学式
C16H14O3
mdl
MFCD00021705
分子量
254.285
InChiKey
NHUQYXSTNXLJIW-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    189 °C
  • 沸点:
    386.9±27.0 °C(Predicted)
  • 密度:
    1.204±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.5
  • 重原子数:
    19
  • 可旋转键数:
    4
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.062
  • 拓扑面积:
    46.5
  • 氢给体数:
    1
  • 氢受体数:
    3

SDS

SDS:7fea8238dd66fdce11366f7fdbe74394
查看

反应信息

点击查看最新优质反应信息

文献信息

  • Access to α,β-unsaturated carboxylic acids through water-soluble palladium catalyzed hydroxycarbonylation of alkynes using water as the solvent
    作者:Jinhe Lv、Lingbo Zong、Jinrong Zhang、Jiaxin Song、Jinyu Zhao、Kai Zhang、Ziqin Zhou、Mingjie Gao、Congxia Xie、Xiaofei Jia、Xinyi Ren
    DOI:10.1039/d1cy00699a
    日期:——
    β-unsaturated carboxylic acids from alkynes with CO and H2O was described. The atom-economic hydroxycarbonylation of various symmetrical and unsymmetrical alkynes can be achieved with chemo-, stereo-, and regioselectivity, affording the corresponding carboxylic acids in good to excellent yields. Using water as the reaction solvent, the water-soluble palladium catalyst was easily separated from the product and
    描述了亚砜磷改性的钯催化从炔烃与 CO 和 H 2 O合成 α,β-不饱和羧酸。各种对称和不对称炔烃的原子经济羟基羰基化可以通过化学选择性、立体选择性和区域选择性实现,从而以良好到优异的产率提供相应的羧酸。以水为反应溶剂,水溶性钯催化剂容易与产物分离,可重复使用5次。
  • Synthesis of Vinyl Carboxylic Acids using Carbon Dioxide as a Carbon Source by Iron-Catalyzed Hydromagnesiation
    作者:Rajagopal Santhoshkumar、Ya-Chun Hong、Ching-Zong Luo、Yun-Ching Wu、Chen-Hsun Hung、Kuen-Yuan Hwang、An-Pang Tu、Chien-Hong Cheng
    DOI:10.1002/cctc.201600279
    日期:2016.7.6
    iron‐catalyzed synthesis of α,β‐unsaturated carboxylic acids from alkynes and carbon dioxide was developed. This reaction proceeds through hydromagnesiation of alkynes followed by carbon dioxide insertion under atmospheric pressure and ambient temperature in the presence of iron and a Grignard reagent as a catalyst and hydride source, respectively. Several symmetrical and unsymmetrical alkynes were transformed
    开发了由炔烃和二氧化碳铁催化的α,β-不饱和羧酸的合成方法。该反应通过炔烃的加氢放大进行,然后在大气压和环境温度下分别在铁和格氏试剂作为催化剂和氢化物源的存在下插入二氧化碳。几种对称和不对称炔烃以良好或优异的收率转化为相应的酸。该方法提供了合成乙烯基羧酸的有效途径。
  • [EN] PYRIDINE DERIVATIVES USEFUL FOR INHIBITING SODIUM/CALCIUM EXCHANGE SYSTEM<br/>[FR] DERIVES PYRIDINE SERVANT A INHIBER LE SYSTEME D'ECHANGE SODIUM/CALCIUM
    申请人:ORION CORP
    公开号:WO2004063191A1
    公开(公告)日:2004-07-29
    Therapeutically active compounds of formula (I) or (II) wherein X is -O-, -CH2- or -C(O)-; Z is -CHR12- or a valence bond; Y is -CH2-, -C(O)-, CH(OR13)-, -O-, -S-; provided that in case Z is a valence bond, Y is not C(O); the dashed line representing an optional double bond in which case Z is -CR12- ­and Y is -CH2-, -C(O)- or -CH(OR10)- (in formula II) or -CH- (in formula I); R2 and R3 are independently H, lower alkyl, lower alkoxy, -NO2, halogen, -CF3, -OH, benzyloxy or a group of formula (IIIa). R1 is H, CN, halogen, -CONH2, -COOR15, CH2NR15R18, NHC(O)R5, NHCH2R5, NHR20, NR21R22, NHC(NH)NHCH3 or, in case the compound is of formula (II) wherein the optional double bond exists or in case R2 or R3 is benzyloxy or a group of formula (IIIa) or in case the pyridine ring of formula (I) or (II) is attached to the oxygen atom in 3-, 4- or 5-position, R1 can also be -NO2 or NR16R17; R4 is H, -NO2, CN, halogen, -CONH2, -COOR15, -CH2NR15R18, -NR16R17, NHC(O)R5 or -NHC(NH)NHCH3; R5 is alkyl substituted with 1-3 substituents selected from the group consisting of halogen, amino and hydroxy, or carboxyalkyl, in which the alkyl portion is optionally substituted with 1-3 substituents selected from the group consisting of halogen, amino and hydroxyl, -CHR6NR,R8 or one of the following groups: formula (IVa), (IVb), (IVc), (IVd), (IVe), and pharmaceutically acceptable salts and esters thereof. The compounds are potent inhibitors of Na+/Ca2+ exchange mechanism.
    式(I)或(II)的治疗活性化合物,其中X为-O-,-CH2-或-C(O)-;Z为-CHR12-或一个价键;Y为-CH2-,-C(O)-,CH(OR13)-,-O-,-S-;条件是如果Z为一个价键,则Y不是C(O);虚线表示可选的双键,此时Z为-CR12-,Y为-CH2-,-C(O)-或-CH(OR10)-(在式(II)中)或-CH-(在式(I)中);R2和R3独立地为H,较低的烷基,较低的烷氧基,-NO2,卤素,-CF3,-OH,苄氧基或式(IIIa)的基团。R1为H,CN,卤素,-CONH2,-COOR15,CH2NR15R18,NHC(O)R5,NHCH2R5,NHR20,NR21R22,NHC(NH)NHCH3的基团,或者,如果化合物为式(II),其中存在可选的双键,或者如果R2或R3为苄氧基或式(IIIa)的基团,或者如果式(I)或(II)的吡啶环附着在3-,4-或5-位置的氧原子上,则R1也可以是-NO2或NR16R17;R4为H,-NO2,CN,卤素,-CONH2,-COOR15,-CH2NR15R18,-NR16R17,NHC(O)R5或-NHC(NH)NHCH3;R5为烷基,其上取代有1-3个取自卤素、氨基和羟基或羧基的取代基,其中烷基部分可选地取代有1-3个取自卤素、氨基和羟基的取代基,-CHR6NR,R8或以下所示的一个基团之一:式(IVa),(IVb),(IVc),(IVd),(IVe),以及其药用可接受的盐和酯。这些化合物是Na+/Ca2+交换机制的有效抑制剂。
  • A convenient way to dibenzo[c,h]-1,5-naphthyridines (11-aza-benzo[c] phenanthridines)
    作者:Emile Bisagni、Corinne Landras、Sylvie Thirot、Christiane Huel
    DOI:10.1016/0040-4020(96)00579-0
    日期:1996.7
    Whereas thermal cyclisation of variously substituted 2,3-diarylacrylazides easily provided a new way to 3-aryl-isoquinolones, nitration of these compounds mainly led to corresponding 3-aryl-4-nitro-isoquinolones. After reduction into 4-amino-3-aryl-isoquinolones, amidification and subsequent cyclization gave the yet unknown title compounds.
    尽管各种取代的2,3-二芳基丙烯酰胺的热环化很容易为3-芳基-异喹诺酮提供了新的途径,但这些化合物的硝化作用主要产生了相应的3-芳基-4-硝基-异喹诺酮。还原成4-氨基-3-芳基-异喹诺酮后,酰胺化和随后的环化反应产生了未知的标题化合物。
  • Enantioselective hydrogenation of α,β-unsaturated carboxylic acid over cinchonidine-modified Pd nanoparticles confined in carbon nanotubes
    作者:Zaihong Guan、Shengmei Lu、Can Li
    DOI:10.1016/j.jcat.2013.10.010
    日期:2014.3
    We report the enantioselective hydrogenation of α,β-unsaturated acid catalyzed by Pd nanoparticles in carbon nanotubes (CNTs) taking the advantage of the channels as nanoreactors. The Pd nanocatalyst inside the channels of CNTs shows higher activity and enantioselectivity than that of Pd nanocatalyst outside the channels. As high as 92% enantioselectivity is achieved. The enhanced catalytic performance
    我们报告碳纳米管(CNTs)中的Pd纳米粒子利用通道作为纳米反应器的优势催化α,β-不饱和酸的对映选择性氢化。CNT通道内的Pd纳米催化剂比通道外的Pd纳米催化剂具有更高的活性和对映选择性。达到高达92%的对映选择性。增强的催化性能归因于CNT通道中反应物,手性改性剂和添加剂的富集。这项工作证明了CNTs作为用于不对称催化反应的纳米反应器的独特功能。
查看更多

同类化合物

(E,Z)-他莫昔芬N-β-D-葡糖醛酸 (E/Z)-他莫昔芬-d5 (4S,5R)-4,5-二苯基-1,2,3-恶噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4R,4''R,5S,5''S)-2,2''-(1-甲基亚乙基)双[4,5-二氢-4,5-二苯基恶唑] (1R,2R)-2-(二苯基膦基)-1,2-二苯基乙胺 鼓槌石斛素 高黄绿酸 顺式白藜芦醇三甲醚 顺式白藜芦醇 顺式己烯雌酚 顺式-桑皮苷A 顺式-曲札芪苷 顺式-二苯乙烯 顺式-beta-羟基他莫昔芬 顺式-a-羟基他莫昔芬 顺式-3,4',5-三甲氧基-3'-羟基二苯乙烯 顺式-1,2-二苯基环丁烷 顺-均二苯乙烯硼酸二乙醇胺酯 顺-4-硝基二苯乙烯 顺-1-异丙基-2,3-二苯基氮丙啶 阿非昔芬 阿里可拉唑 阿那曲唑二聚体 阿托伐他汀环氧四氢呋喃 阿托伐他汀环氧乙烷杂质 阿托伐他汀环(氟苯基)钠盐杂质 阿托伐他汀环(氟苯基)烯丙基酯 阿托伐他汀杂质D 阿托伐他汀杂质94 阿托伐他汀内酰胺钠盐杂质 阿托伐他汀中间体M4 阿奈库碘铵 银松素 铒(III) 离子载体 I 钾钠2,2'-[(E)-1,2-乙烯二基]二[5-({4-苯胺基-6-[(2-羟基乙基)氨基]-1,3,5-三嗪-2-基}氨基)苯磺酸酯](1:1:1) 钠{4-[氧代(苯基)乙酰基]苯基}甲烷磺酸酯 钠;[2-甲氧基-5-[2-(3,4,5-三甲氧基苯基)乙基]苯基]硫酸盐 钠4-氨基二苯乙烯-2-磺酸酯 钠3-(4-甲氧基苯基)-2-苯基丙烯酸酯 重氮基乙酸胆酯酯 醋酸(R)-(+)-2-羟基-1,2,2-三苯乙酯 酸性绿16 邻氯苯基苄基酮 那碎因盐酸盐 那碎因[鹼] 达格列净杂质54 辛那马维林 赤藓型-1,2-联苯-2-(丙胺)乙醇 赤松素 败脂酸,丁基丙-2-烯酸酯,甲基2-甲基丙-2-烯酸酯,2-甲基丙-2-烯酸